InsidersTradesSigma
Track the BEONE MEDICINES LTD share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €42.6bn. The latest transaction was filed on 25 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN V OYLER. All data is free.
Analysts rate BEONE MEDICINES LTD Strong Buy (bullish), based on 28 analysts. Average price target: US$432.16.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
BEONE MEDICINES LTD is a company focused on developing innovative medical treatments. It is listed on the NASDAQ.